Diabetes Technology News

2023

• April 25, 2023 Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod
• April 24, 2023 Lilly to Divest BAQSIMI to Amphastar
• April 21, 2023 FDA Approves Medtronic MiniMed™ 780G System
• April 14, 2023 FDA Clears Reader For Abbott's Freestlye Libre® 3 System
• March 16, 2023 Insulin Price Cuts
• March 13, 2023 Time in Tight Range: A New Diabetes Goal?
• March 6, 2023 U.S. FDA Clears Abbott's Freestyle Libre® 3 And Freestyle Libre® 3 Sensors For Integration With Automated Insulin Delivery Systems
• March 2, 2023 Medicare to expand CGM coverage to more Type 2 diabetes patients (MedtechDive)
• March 2, 2023 Bigfoot Biomedical Receives FDA Clearance for Bigfoot Unity® Android App for People Living with Insulin-Requiring Diabetes
• February 14, 2023 Standards of Care Begin to Reflect Advances in Diabetes Technology
• January 26, 2023 Diabetes Technology: FDA Approves Abbott's Spinal Cord Stimulation for People Living with Diabetes
• January 24, 2023 New HHS Report Finds Major Savings for Americans Who Use Insulin
• January 24, 2023 Tidepool Loop Receives FDA Clearance

2022

• December 23, 2022 FDA approves once-weekly Wegovy injection for the treatment of obesity in teens aged 12 years and older
• December 8, 2022 Dexcom G7 Now FDA Approved!
• November 22, 2022 Medtronic Extended infusion set and reservoir
• September 7, 2022 Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon)
• August 22, 2022 Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes
• August 4, 2022 Tandem lines up FDA review of new pint-sized insulin pump amid lower-than-expected sales
• July 2022 Mobile Bolus feature now available for Tandem t:slim X2 pump users with a compatible smartphone
• May 31, 2022 Libre 3 now FDA approved
• March 30, 2022 Sugar.IQ™ App Discontinuation (Medtronic Guardian™ Connect System)
• March 14, 2022 Dexcom G7 received CE mark
• February 16, 2022 First Smartphone App FDA cleared for Insulin Delivery on Both iOS and Android Operating Systems
• February 16, 2022 Insulet Promotes Inclusivity for People with Diabetes through Nintendo® Video Game Animal Crossing™: New Horizons
• February 11, 2022 Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months
• January 28, 2022 Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control
• January 3, 2022 New FDA Approved Insulin Marks Another Win for Insulin Affordability

2021

• December 16, 2021 Digitizing Diabetes Management with T1D Apps
• December 15, 2021 Racial disparities in diabetes technology use widen among Medicare beneficiaries
• December 8, 2021 Tandem Diabetes Care Plans for Future with Technology Choices
• December 5, 2021 Get Up Close and in the Know with Sean Salmon, President of Medtronic Diabetes 
• December 3, 2021 Mobile App Interventions to Improve Medication Adherence Among Type 2 Diabetes Mellitus Patients: A Systematic Review of Clinical Trials
• November 22, 2021 CGM as medicine: Technology benefits extend to type 2 diabetes 
• November 19, 2021 U.S. House votes to cap insulin cost at $35 per month
• November 11, 2021 After another successful quarter, diabetes tech players look ahead to key product launches
• October 2021 Status Update: Connected Insulin Delivery Devices 
• October 2021 Resources: Connected Insulin Delivery Devices
• October 25, 2021 What's in Your Diabetes Toolkit?
• October 13, 2021 Tips for using diabetes apps in practice
• October 2, 2021 Highlights from EASD 2021
• September 30, 2021 Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use
• September 24, 2021 Six Digital Health Technologies That Will Transform Diabetes
• August 2021 Status Update: Automated Insulin Delivery Devices 
• August 30, 2021 FDA Approves 7-day Infusion Set
• August 23, 2021 What Are the Best Apps Out There for Improving Your Health?
• August 16, 2021 New diabetes technology is expected to improve customization, availability of real-time data
• August 16, 2021 Newest Updates in Diabetes Care and Education from ADCES 2021
• August 15, 2021 Embrace diabetes apps as part of a technology-enabled practice
• August 5, 2021 Technology Disparities and Therapeutic Inertia: A Call to Action for the Diabetes Care and Education Specialist
• August 2, 2021 FDA Approves Exenatide for Children and Teens with Type 2 Diabetes
• August 2, 2021 Abbott's Freestyle® Libre 2 iOS app cleared in U.S.
• July 8, 2021 8 Great CGM and Insulin Pump Patches for People with Diabetes
• July 6, 2021 Highlights of the American Diabetes Association’s 2021 Annual Meeting
• June 30, 2021 What You Should Know About Walmart’s Newest Low-Cost Insulin
• June 28, 2021 Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use Both Afrezza® And Continuous Glucose Monitoring Devices Beginning July 18
• June 26, 2021 Insulet’s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan
• June 7, 2021 The Latest News in Diabetes Technology – More from ATTD 2021
• June 4, 2021 FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014
• June 3, 2021 Senseonics Announces Results of the PROMISE Study Demonstrating Strong Accuracy of 180 Day CGM Sensor
• June 2, 2021 The Biggest News in Diabetes Technology: Opening Day at ATTD 2021
• May 10, 2021 Bigfoot Biomedical® Receives FDA Clearance for Bigfoot Unity™ Diabetes Management System
• May 6, 2021 Lilly inks smart insulin pen deals with Roche, Dexcom and more

2020

• June 17, 2020 Tandem Diabetes Care Announces Expanded Pediatric Indication of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology 
• June 15, 2020 FDA approves Lyumjev™ (insulin lispro-aabc injection), Lilly's new rapid-acting insulin
• June 13, 2020 Medtronic Shares Study Results on First of Its Kind Extended Wear Infusion Set from American Diabetes Association Conference 
• June 12, 2020 Medtronic Presents U.S. Pivotal Trial Data for MiniMed™ 780G Advanced Hybrid Closed Loop System with Automated Correction Bolus Feature 
• March 26, 2020 Senseonics Suspends Commercial US Sales of Eversense in Response to COVID-19
• March 25, 2020 Top Nine Tips For Diving Into Telemedicine With Your Doctor During COVID-19
• January 6, 2020 Ketone Checks Made Easy: New Meter Measures Ketones in Breath
• January 5, 2020 New Diabetes Technology to Watch for in 2020

2019

• December 17, 2019 Bionic Pancreas System Receives Breakthrough Device Designation From FDA
• December 16, 2019 Tandem’s Control-IQ Cleared in United States
• December 13, 2019 FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system
• December 2, 2019 Users of the only long-term implantable CGM system can now manage their diabetes treatment decisions without a fingerstick confirmation
• September 20, 2019 The US Food and Drug Administration (FDA) approved the first oral GLP-l treatment for type 2 diabetes in adults.
• September 10, 2019 FDA OKs Easy-to-Use Glucagon Rescue Pen for Severe Hypos in Diabetes
• July 7, 2019 FDA approves first treatment for severe hypoglycemia that can be administered without an injection. 

2018

• August 16, 2018 Companion Medical and One Drop Announce Partnership in Integrated Diabetes Management
• August 1, 2018 Lilly Diabetes Solution Center Now Open to Help People with Insulin Affordability
• August 2018 Are Blood Glucose Meters Accurate? New Data on 18 Meters from the Blood Glucose Monitoring System Surveillance Program
• June 22, 2018 FDA expands approval of Medtronic MiniMed 670G to include kids 7 and up
• June 22, 2018 Senseonics gets FDA clearance for Eversense, will sell implantable glucose monitor directly in US
• June 21, 2018 Tandem Diabetes Care Announces FDA Approval of t:slim X2 Insulin Pump with Basal-IQ Technology
• June 11, 2018 Dexcom G5 Continuous Glucose Monitoring System Now Available on Mobile, Smart Devices for Medicare Patients with Diabetes
• March 22, 2018 FDA Authorizes Marketing of the New Dexcom G6 CGM Eliminating the Need for Fingerstick Blood Testing for People with Diabetes
• February 14, 2018 FDA Clears Glooko’s Long-Acting Insulin Titration System
• February 5, 2018 Omnipod now being covered by Medicare Part D
• February 5, 2018 InPen launches in US (Medscape article here)

2017

• December 5, 2017 Ozempic® (semaglutide) approved in the US
• October 5, 2017 Animas Corporation to Close Operations and Exit Insulin Pump Market
• September 29, 2017 Novo Nordisk Receives FDA Approval for Fiasp®, a New Fast-Acting Mealtime Insulin
• September 27, 2017 Abbott Introduces the FreeStyle Libre Flash Glucose Monitoring System
• January 13, 2017 CMS to Recognize CGMs for Treatment Decisions in Diabetes  (requires login)

2016

• December 20, 2016 FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions
• December 3, 2016 Lilly Announces Program to Provide Insulin at Discounted Prices
• December 2, 2016 FDA approved Jardiance to reduce cardiovascular death in adults with type 2 diabetes
• November 21, 2016 Ascensia Diabetes Care receives FDA clearance for the app-enabled Contour® Next One blood glucose monitoring system
• November 21, 2016 Sanofi receive FDA approval of Soliqua™ 100/33 for the treatment of adults with Type 2 Diabetes
• November 21, 2016 Novo Nordisk receives U.S. FDA approval for Xultophy® 100/3.6
• October 31, 2016 Press Release re: U-500 dedicated syringe now available
• April 2, 2016 Go, Team Coco! published digitally by Disney and Lilly Diabetes
• March 30, 2016 Large cohort study confirms link between pioglitazone, bladder cancer
• March 18, 2016 Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety official publication, and American Diabetes Association's Official Statement
• March 15, 2016 Smartphone-connected glucometer Dario launches in US after FDA clearance
• February 2, 2016 Insulet to Divest Neighborhood Diabetes Supplies Business
• January 11, 2016 Insulet Enters into Development Agreement with Eli Lilly for OmniPod Delivery of u200 Concentrated Insulin
• January 7, 2016 FDA approves Integra Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers